BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2842022)

  • 1. Dietary fish oils containing eicosapentaenoic acid and the prevention of atherosclerosis and thrombosis.
    Holub BJ
    CMAJ; 1988 Sep; 139(5):377-81. PubMed ID: 2842022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
    Pauwels EK; Kostkiewicz M
    Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary effects of fish oils on human health: a review of recent studies.
    Kantha SS
    Yale J Biol Med; 1987; 60(1):37-44. PubMed ID: 3551346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-thrombotic and anti-atherogenic action of eicosapentaenoic acid].
    Tamura Y; Hirai A; Terano T; Saitoh H
    Nihon Rinsho; 1992 Feb; 50(2):403-7. PubMed ID: 1613998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atheroma and fish oils].
    Marcantoni JP; Biason P
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():175-80. PubMed ID: 1285700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of omega-3-fatty acids on the prostaglandin system in healthy probands].
    Gazsó A; Kaliman J; Horrobin DF; Sinzinger H
    Wien Klin Wochenschr; 1989 Apr; 101(8):283-8. PubMed ID: 2543143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
    Holub BJ
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short report: the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention.
    Sacks FM; Hebert P; Appel LJ; Borhani NO; Applegate WB; Cohen JD; Cutler JA; Kirchner KA; Kuller LH; Roth KJ
    J Hypertens; 1994 Feb; 12(2):209-13. PubMed ID: 8021472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What can we expect from omega-3 fatty acids?
    Chan EJ; Cho L
    Cleve Clin J Med; 2009 Apr; 76(4):245-51. PubMed ID: 19339640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different ratios of eicosapentaenoic and docosahexaenoic omega-3 fatty acids in commercial fish oils differentially alter pro-inflammatory cytokines in peritoneal macrophages from C57BL/6 female mice.
    Bhattacharya A; Sun D; Rahman M; Fernandes G
    J Nutr Biochem; 2007 Jan; 18(1):23-30. PubMed ID: 16563716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dietary fish oil and omega-3 fatty acids on platelets and blood vessels.
    Goodnight SH
    Semin Thromb Hemost; 1988 Jul; 14(3):285-9. PubMed ID: 2845585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A practical approach to increasing intakes of n-3 polyunsaturated fatty acids: use of novel foods enriched with n-3 fats.
    Metcalf RG; James MJ; Mantzioris E; Cleland LG
    Eur J Clin Nutr; 2003 Dec; 57(12):1605-12. PubMed ID: 14647226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids from fish oils and cardiovascular disease.
    Holub DJ; Holub BJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):217-25. PubMed ID: 15524182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of effects of dietary fish oil supplementation on serum eicosapentaenoic acid and docosahexaenoic acid concentrations in dogs.
    Hansen RA; Ogilvie GK; Davenport DJ; Gross KL; Walton JA; Richardson KL; Mallinckrodt CH; Hand MS; Fettman MJ
    Am J Vet Res; 1998 Jul; 59(7):864-8. PubMed ID: 9659553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biological actions and potential clinical significance of dietary omega-3 fatty acids.
    Gorlin R
    Arch Intern Med; 1988 Sep; 148(9):2043-8. PubMed ID: 3046544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of N-3 PUFAS on plasma lipoprotein levels and fatty acid composition of total serum and erythrocyte lipids in hypertriglyceridemic patients.
    Putadechakum S; Tanphaichitr V; Leelahagul P; Pakpeankitvatana V; Surapisitchart T; Komindr S
    J Med Assoc Thai; 2005 Feb; 88(2):181-6. PubMed ID: 15962668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids--a review.
    Weber P; Raederstorff D
    Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):28-37. PubMed ID: 10812585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary fatty acids, serum lipids, platelet biochemistry and function.
    Galli C; Mosconi C; Medini L; Tremoli E
    Wien Klin Wochenschr; 1989 Apr; 101(8):267-71. PubMed ID: 2658330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vein graft intimal thickening by eicosapentanoic acid: reduced thromboxane production without change in lipoprotein levels or low-density lipoprotein receptor density.
    Cahill PD; Sarris GE; Cooper AD; Wood PD; Kosek JC; Mitchell RS; Miller DC
    J Vasc Surg; 1988 Jan; 7(1):108-18. PubMed ID: 3336117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.